About this trial
The purpose of this study is to determine whether the use of a weighted blanket improves pain and anxiety among adult trauma inpatients. Participants will be randomly assigned to receive either a weighted blanket or the standard hospital blanket routinely provided during hospitalization. Pain scores documented as part of routine clinical care and participant-reported anxiety ratings will be compared between groups. This study will evaluate whether weighted blankets may serve as a non-pharmacologic adjunct to pain and anxiety management for adult trauma inpatients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 18 to 89 years
Patients admitted to the trauma service at Dell Seton Medical Center
Glasgow Coma Scale (GCS) score of 15 at the time of enrollment
Able to provide informed consent and participate in study assessments
Disqualifiers
Age younger than 18 years
Age older than 89 years
Pregnant patients
Intubated or mechanically ventilated patients
Trial design
Parallel
Treatments tested in this trial
Weighted Blanket
DeviceA commercially available weighted blanket provided by the study for use during hospitalization as a non-pharmacologic adjunct to routine trauma care. Participants will be encouraged to use the blanket while in bed or seated in a chair and may discontinue use at any time.
Standard Hospital Blanket
DeviceThe standard hospital blanket routinely provided during hospitalization and used as the comparator to the weighted blanket. Participants will be encouraged to use the blanket while in bed or seated in a chair and may discontinue use at any time.
Treatment groups
Trial outcomes
Primary outcomes
Pain Intensity
Pain intensity will be assessed using routinely documented Numeric Pain Rating Scale (NPRS) scores collected from the electronic medical record as part of standard clinical care, typically every 6 to 8 hours. The NPRS ranges from 0 to 10, with higher scores indicating greater pain intensity. For each participant, all available NPRS scores within each 24-hour study period following enrollment/randomization will be averaged to calculate one average daily pain score.
Secondary outcomes
Anxiety
Anxiety will be assessed daily using the Anxiety Visual Analog Scale (VAS), a 100-millimeter horizontal line anchored by "Not at all anxious" (0 mm) on the left and "Extremely anxious" (100 mm) on the right. Scores range from 0 to 100 mm, with higher scores indicating greater anxiety (a worse outcome).
Opioid Utilization
Opioid utilization will be calculated as daily morphine milligram equivalents (MME) using opioid medications documented in the electronic medical record. For each participant, daily MME will be calculated for each available 24-hour study period following enrollment/randomization.
Length of Hospital Stay
Total inpatient hospital length of stay will be calculated from the date of hospital admission through the date of hospital discharge using data obtained from the electronic medical record and reported in days.
Average Daily Systolic Blood Pressure
Systolic blood pressure measurements documented in the electronic medical record as part of standard clinical care will be collected. For each participant, all available systolic blood pressure measurements within each 24-hour study period following enrollment/randomization will be averaged to calculate one average daily systolic blood pressure value, reported in millimeters of mercury (mmHg).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: